PE20000174A1 - PYRIDINYLPYRIMIDINAMINES - Google Patents
PYRIDINYLPYRIMIDINAMINESInfo
- Publication number
- PE20000174A1 PE20000174A1 PE1999000018A PE00001899A PE20000174A1 PE 20000174 A1 PE20000174 A1 PE 20000174A1 PE 1999000018 A PE1999000018 A PE 1999000018A PE 00001899 A PE00001899 A PE 00001899A PE 20000174 A1 PE20000174 A1 PE 20000174A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- halogen
- refers
- compound
- alcoxy
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical group 0.000 abstract 3
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical class F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 2
- 108060003951 Immunoglobulin Proteins 0.000 abstract 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 102000018358 immunoglobulin Human genes 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- -1 3-METHYLPHENYL Chemical class 0.000 abstract 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 abstract 1
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 201000009961 allergic asthma Diseases 0.000 abstract 1
- 208000002205 allergic conjunctivitis Diseases 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 208000024998 atopic conjunctivitis Diseases 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
SE REFIERE AL NUEVO USO DE PIRIDINILPIRIMIDINAMINAS DE FORMULA I; R1 ES HALOGENO, FENILO, ALQUILO; R2 ES H, HALO, ALQUILO, ALCOXI, TRIFLUOROMETILO, EN LA PREPARACION DE UN MEDICAMENTO PARA LA TERAPIA DE ENFERMEDADES MEDIADAS POR IgE (INMUNOGLOBULINA E). TAMBIEN SE REFIERE A UN COMPUESTO DE FORMULA Ib DONDE; R1`' ES HALOGENO CON UN NUMERO ATOMICO 17 o 35 Y R2'' ES H o ALCOXI O BIEN R1'' ES FENILO O ALQUILO, R2'' ES H, HALOGENO, ALQUILO, ALCOXI, TRIFLUOROMETILO. UN COMPUESTO PREFERIDO N-(3-METILFENIL)-N-[4-(2-METILPIRIDIN-4-IL)PIRIMIDIN-2-IL]AMINA. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I ACTUA COMO INHIBIDOR ESPECIFICO DE LA SINTESIS DE INMUNOGLOBULINA E (IgE) EN LOS LINFOCITOS B Y PUEDE SER UTIL PARA EL TRATAMIENTO DE ENFERMEDADES TAL COMO DERMATITIS ATOPICA, ASMA ALERGICA, CONJUNTIVITIS ALERGICA Y RINITIS ALERGICAREFERS TO THE NEW USE OF PYRIDINYLPYRIMIDINAMINES OF FORMULA I; R1 IS HALOGEN, PHENYL, ALKYL; R2 IS H, HALO, ALKYL, ALCOXY, TRIFLUOROMETHYL, IN THE PREPARATION OF A DRUG FOR THE THERAPY OF IgE-MEDIATED DISEASES (IMMUNOGLOBULIN E). ALSO REFERS TO A COMPOUND OF FORMULA Ib WHERE; R1` 'IS HALOGEN WITH AN ATOMIC NUMBER 17 or 35 AND R2' 'IS H or ALCOXI OR R1' 'IS PHENYL OR ALKYL, R2' 'IS H, HALOGEN, ALKYL, ALCOXY, TRIFLUOROMETHYL. A PREFERRED COMPOUND N- (3-METHYLPHENYL) -N- [4- (2-METHYLPYRIDIN-4-IL) PYRIMIDIN-2-IL] AMINE. IT ALSO REFERS TO A PROCEDURE FOR PREPARATION. COMPOUND I ACTS AS A SPECIFIC INHIBITOR OF THE SYNTHESIS OF IMMUNOGLOBULIN E (IgE) IN B LYMPHOCYTES AND MAY BE USEFUL FOR THE TREATMENT OF DISEASES SUCH AS ATOPIC DERMATITIS, ALLERGIC ASTHMA, ALLERGIC CONJUNCTIVITIS AND ALLERGIC RHINITIS
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9800522.6A GB9800522D0 (en) | 1998-01-12 | 1998-01-12 | Organic compounds |
| GBGB9800520.0A GB9800520D0 (en) | 1998-01-12 | 1998-01-12 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20000174A1 true PE20000174A1 (en) | 2000-03-17 |
Family
ID=26312926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000018A PE20000174A1 (en) | 1998-01-12 | 1999-01-08 | PYRIDINYLPYRIMIDINAMINES |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR014288A1 (en) |
| AU (1) | AU2516199A (en) |
| CO (1) | CO4940461A1 (en) |
| PE (1) | PE20000174A1 (en) |
| WO (1) | WO1999035140A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0025820D0 (en) * | 2000-10-20 | 2000-12-06 | Novartis Ag | Organic compounds |
| US6706703B2 (en) | 2001-06-29 | 2004-03-16 | Kowa Co., Ltd. | Bis(5-aryl-2-pyridyl) derivatives |
| US6890940B2 (en) | 2001-06-29 | 2005-05-10 | Kowa Co., Ltd. | Bis(2-aryl-5-pyridyl) derivatives |
| AR038368A1 (en) * | 2002-02-01 | 2005-01-12 | Novartis Ag | N-PYRIMIDIN-2-IL-AMINAS SUBSTITUTED COMPOUNDS AS IGE INHIBITORS, A PHARMACEUTICAL COMPOSITION AND THE USE OF SUCH COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT |
| US20110294810A1 (en) * | 2008-11-14 | 2011-12-01 | Christian Beier | Substituted (pyridyl)-azinylamine derivatives as plant protection agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3474817D1 (en) * | 1983-09-01 | 1988-12-01 | Boehringer Ingelheim Ltd | Diazine-ethenylphenyl oxamic acids and esters and salts thereof |
| DK0672041T3 (en) * | 1993-10-01 | 2002-02-25 | Novartis Ag | Pharmacologically active pyridine derivatives and processes for their preparation |
| ATE325113T1 (en) * | 1993-10-01 | 2006-06-15 | Novartis Pharma Gmbh | PHARMACOLOGICALLY ACTIVE PYRIMIDINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF |
-
1999
- 1999-01-08 AU AU25161/99A patent/AU2516199A/en not_active Abandoned
- 1999-01-08 WO PCT/EP1999/000060 patent/WO1999035140A1/en not_active Ceased
- 1999-01-08 PE PE1999000018A patent/PE20000174A1/en not_active Application Discontinuation
- 1999-01-11 AR ARP990100084A patent/AR014288A1/en unknown
- 1999-01-12 CO CO99001220A patent/CO4940461A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO4940461A1 (en) | 2000-07-24 |
| WO1999035140A1 (en) | 1999-07-15 |
| AU2516199A (en) | 1999-07-26 |
| AR014288A1 (en) | 2001-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20030238A1 (en) | USE OF NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF BRAIN, SPINAL AND NEURONAL INJURIES | |
| NZ332477A (en) | Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors | |
| PE20020467A1 (en) | 1,4-DIHYDROPYRIDINE COMPOUNDS AS BRADYCININ ANTAGONISTS | |
| BR0309522A (en) | Pyridine compounds or salts thereof and herbicides containing them | |
| TW365603B (en) | Novel perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them | |
| EE04310B1 (en) | Benzimidazole compounds, pharmaceutical compositions containing these compounds and their use | |
| EE9700282A (en) | Benzimidazole compounds, pharmaceutical compositions containing said compounds and their use | |
| NO20030471L (en) | Carboxamide compounds and their use as antagonists for an 11CBY receptor | |
| DE60206164D1 (en) | TRISUBSTITUTED-N - ((1S) -1,2,3,4-TETRAHYDRO-1-NAPHTHALENYL) BENZAMIDES INHIBITING P2X3 AND P2X2 / 3 CONTAINING RECEPTORS | |
| ATE416157T1 (en) | INHIBITORS OF INTEGRIN ALPHA-V-BETA-6 | |
| CO4650183A1 (en) | DERIVATIVES OF PIRROL | |
| NO20022470D0 (en) | pyrimidine | |
| BR9806568A (en) | Crystal form of n- (4-trifluormethylphenyl) -5-methylisoxazole-4-carboxamide | |
| PE20000174A1 (en) | PYRIDINYLPYRIMIDINAMINES | |
| YU64901A (en) | Biphenyl derivatives | |
| DE60121048D1 (en) | PYRAZINOi1'2 ': 1,6öPYRIDOi3,4-BöINDOLDERIVATE | |
| DK0847384T3 (en) | Carbamoylcarboxylic acid amides | |
| ATE313528T1 (en) | 4-(PHENYL(PIPERIDIN-4-YL)AMINO) BENZAMIDE DERIVATIVES AND THE USE THEREOF FOR THE TREATMENT OF PAIN, ANXIETY OR GASTROINTESTINAL DISORDERS | |
| NZ333229A (en) | ||
| ATE287400T1 (en) | 4-(PHENYLPIPERIDINE-4-YLIDENMETHYL) BENZAMIDE DERIVATIVES AND THE USE THEREOF FOR THE TREATMENT OF PAIN, ANXIETY OR GASTROINTESTINAL DISORDERS | |
| ATE293591T1 (en) | NEW N-(2-PHENYL-3-AMINOPROPYL)NAPHTAMIDE | |
| AR026244A1 (en) | COMPOUNDS | |
| BG103395A (en) | Derivatives of benzenesulphonamide and medicaments containing them | |
| DE69402058D1 (en) | PERHYDROISOINDOL DERIVATIVES, THE PRODUCTION THEREOF AND THE PHARMACEUTICAL SUMMARIES CONTAINING THEM | |
| DE59814233D1 (en) | Indolmethyl-N, N'-bisacylpiperazines as neurokinin receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |